Clinical Trial Update: Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the effect of oral N-acetylcysteine on brain glutathione levels and schizophrenia symptom outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED